Figure 3. Abdominal MRI performed after first-line treatment with triclabendazole.
The abdominal MRI shows an increase in the size of the pseudonodular hepatic lesions (arrows).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.